← Back to Search

Intervention Auricular Acupressure (AA) Group for Opioid Use Disorder

N/A

Waitlist Available

Led By Heather Columbano, M.D.

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, day 1, day 2, and day 3

Awards & highlights

Study Summary

This trial aims to see if adding auricular acupressure to existing meds for chronic pain can reduce pain and reliance on medication.

Eligible Conditions

Opioid Use Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, day 1, day 2, and day 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, day 1, day 2, and day 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 1, day 2, and day 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Pain, Enjoyment and General Activity (PEG) Assessment scores

pain scores using Numerical Rating Scale (NRS)

Secondary outcome measures

Auricular Acupressure Acceptability

Change in Patient Global Impression of Change (PGIC) scores

Changes in Patient-Reported Outcomes Measurement Information System (PROMIS)

+4 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention Auricular Acupressure (AA) GroupExperimental Treatment1 Intervention

Participants will participate in the Auricular Acupressure intervention over 3 days in addition to the Standard of Care treatment for Chronic Pain and complete questionnaires

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Auricular Acupressure with Vaccaria 600t ear seeds

2023

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,241 Previous Clinical Trials

1,004,216 Total Patients Enrolled

Heather Columbano, M.D.Principal InvestigatorAtrium Health Wake Forest Baptist

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots still available for enrolment in this experiment?

"Unfortunately, the clinical trial advertised on clinicialtrials.gov is no longer recruiting patients; however, this information was last updated on January 25th 2023 when it was first posted in February 1st of the same year. Thankfully, 1334 other studies are still open for enrollment at this time."

Answered by AI

What is the desired effect of this clinical experiment?

"The primary endpoint used to appraise this trial over the course of 3 days is Pain, Enjoyment and General Activity (PEG) Assessment scores. Subsidiary objectives include assessing patients' willingness to reduce opioid dependency as measured by an Agreement Scale, changes in a Generalized Anxiety Disorder (GAD-7) score based on self-reported symptoms rated 0-3 with higher numbers indicating more intense anxiety, and Pain Catastrophizing Scale (PCS) assessments which assess how much catastrophic thinking is happening due to low back pain through 13 questions ranging from 0 for not at all to 4 for all the time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Auricular Acupressure as a Non-Opioid Adjuvant in Opioid Tolerant Patients

2023. "Auricular Acupressure as a Non-Opioid Adjuvant in Opioid Tolerant Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05711537.